Target intelligence / Profile preview

Cytokines and cytokine regulators

Molecular classification
Signaling protein, Secreted protein, Glycoprotein, Receptor ligand
01

Overview

Cytokines and cytokine regulators encompass a vast family of small signaling proteins and their associated modulating factors that serve as the primary mediators of the immune system [Zhang & An, 2007]. These molecules, which include interleukins, interferons, and chemokines, act in an autocrine, paracrine, or endocrine fashion to regulate cell growth, differentiation, and activation [Dinarello, 2007]. While essential for host defense and tissue repair, the overproduction or chronic expression of cytokines is central to the pathogenesis of autoimmune diseases like rheumatoid arthritis, inflammatory bowel disease, and life-threatening systemic inflammation such as sepsis [Kopf et al., 2010]. Pharmacological strategies targeting this class include monoclonal antibodies that sequester ligands, decoy receptors, and small-molecule inhibitors of downstream signaling pathways like the JAK/STAT axis [Kopf et al., 2010]. Due to their pleiotropic effects, therapeutic modulation of cytokines carries significant risks, most notably an increased susceptibility to serious infections and potential for immune-related adverse events [StatPearls, 2023]. This entry is classified as incorrect because it represents a broad functional category rather than a specific, individual molecular target.

Other names
Immunomodulating agentsInterleukinsInterferonsChemokinesLymphokinesMonokinesCytokine modulators
02

Mechanism of action

Neutralization of circulating ligands, competitive inhibition of cytokine receptors, or inhibition of intracellular signaling transducers such as Janus kinases (JAKs).

03

Biological functions

Immune responseInflammationHematopoiesisCell proliferationApoptosisSignal transduction
04

Disease associations

Autoimmune diseaseCancerInflammationInfectionSepsisCytokine release syndrome
05

Safety considerations

Increased risk of serious infectionsOpportunistic infections (e.g., tuberculosis)Malignancy risk (lymphoma)Cytokine release syndromeInjection site or infusion reactions
06

Interacting drugs

Infliximab

7 more in the full profile.

07

Biomarkers

C-reactive protein (CRP)Interleukin-6 (IL-6) levelsTumor necrosis factor-alpha (TNF-α) levelsErythrocyte sedimentation rate (ESR)

Beyond the preview

Go deeper on Cytokines and cytokine regulators.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Cytokines and cytokine regulators.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call